ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 100 filers reported holding ATHIRA PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,370,690 | -31.5% | 3,153,807 | 0.0% | 0.04% | -31.5% |
| Q2 2023 | $9,303,731 | +58.3% | 3,153,807 | +34.2% | 0.05% | +68.8% |
| Q1 2023 | $5,875,888 | -1.4% | 2,350,355 | +25.0% | 0.03% | -11.1% |
| Q4 2022 | $5,959,080 | +92.8% | 1,879,836 | +80.6% | 0.04% | +80.0% |
| Q3 2022 | $3,091,000 | -2.6% | 1,040,834 | 0.0% | 0.02% | +11.1% |
| Q2 2022 | $3,175,000 | -70.8% | 1,040,834 | +29.1% | 0.02% | -71.4% |
| Q1 2022 | $10,886,000 | +3.6% | 806,367 | 0.0% | 0.06% | +23.5% |
| Q4 2021 | $10,507,000 | +38.9% | 806,367 | 0.0% | 0.05% | +54.5% |
| Q3 2021 | $7,564,000 | -8.4% | 806,367 | 0.0% | 0.03% | -8.3% |
| Q2 2021 | $8,257,000 | -44.3% | 806,367 | 0.0% | 0.04% | -43.8% |
| Q1 2021 | $14,837,000 | -46.3% | 806,367 | 0.0% | 0.06% | -38.5% |
| Q4 2020 | $27,618,000 | +69.6% | 806,367 | -8.6% | 0.10% | +60.0% |
| Q3 2020 | $16,288,000 | – | 882,352 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
| Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
| Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
| Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
| Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
| RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
| Logos Global Management LP | 220,000 | $671,000 | 0.12% |
| PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
| Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
| SG3 Management, LLC | 206,000 | $628,000 | 0.07% |